Close Menu
NEW YORK – The Chan Zuckerberg Initiative and Biohub said on Tuesday they are working with the University of California, San Francisco and Stanford University to increase the Bay Area's novel coronavirus testing capacity by investing in molecular diagnostic platforms from GenMark Diagnostics.
 
The organizations have formed a so-called COVID-19 task force to invest in two GenMark ePlex sample-to-answer molecular diagnostic platforms, one for a CLIA lab at the UCSF Helen Diller Medical Center in Parnassus Heights and one for a CLIA lab at UCSF's Primary Care clinic in C

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.